Vertex to Present at the Goldman Sachs Healthcare Conference on June 7

BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that management will present at the Goldman Sachs Healthcare Conference in Rancho Palos Verde, CA on Tuesday, June 7th at 1:40 p.m. ET (10:40 a.m. PT).

Management’s remarks will be accessible live through Vertex’s website at www.vrtx.com in the “Investors” section under the “Events and Presentations” page. A replay of the conference webcast will be archived on the company’s website.

About Vertex

Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative medicines so people with serious diseases can lead better lives. In addition to our clinical development programs focused on cystic fibrosis, Vertex has more than a dozen ongoing research programs aimed at other serious and life-threatening diseases.

Founded in 1989 in Cambridge, Mass., Vertex today has research and development sites and commercial offices in the United States, Europe, Canada and Australia. For six years in a row, Science magazine has named Vertex one of its Top Employers in the life sciences. For additional information and the latest updates from the company, please visit www.vrtx.com.

(VRTX-WEB)

View source version on businesswire.com: http://www.businesswire.com/news/home/20160531006388/en/

Vertex Pharmaceuticals Incorporated
Investors:
Michael Partridge, 617-341-6108
or
Eric Rojas, 617-961-7205
or
Zach Barber, 617-341-6470

Source: Vertex Pharmaceuticals Incorporated

You May Also Be Interested In

• Truist Securities Assumes Vertex (VRTX) at Buy
• Lleida.net signs a contract for an estimated value of 600,000 euros per year with the company Peruana de Entretenimiento en Línea S.A.C.
• Form 8.5 (EPT/RI) - Abrdn European Logistics Income Plc